The total cash payment to purchase the Notes tendered as of the Consent Payment Deadline, including accrued and unpaid interest up to, but not including, the Early Settlement Date, is approximately $659.5 million. Holders who have not already tendered their Notes may continue to do so at any time at or prior to 11:59 p.m. Eastern time, on October 22, 2009, unless the Co-Issuers extend or earlier terminate the Tender Offer and Consent Solicitation. However, such holders will not be entitled to receive any consent payment, and will instead, be entitled to receive consideration of $1,053.34 per $1,000 of principal amount tendered, plus accrued and unpaid interest from and including the most recent interest payment date, and up to, but excluding, the applicable settlement date. Pursuant to a notice of redemption previously delivered to holders of the Notes, on October 31, 2012 (the “Redemption Date”), the Co-Issuers will redeem any Notes that remain outstanding following the Tender Offer and Consent Solicitation at a redemption price equal to 108.75% of their face amount, plus accrued and unpaid interest from and including the most recent interest payment date, and up to, but excluding, the Redemption Date.

Withdrawal rights for the Tender Offer and Consent Solicitation have expired. Accordingly, holders may not withdraw any Notes previously or hereafter tendered, except as contemplated in the Co-Issuers' Offer to Purchase and Consent Solicitation Statement dated September 24, 2012 (the “Offer to Purchase and Consent Solicitation Statement”). The terms and conditions of the Tender Offer and Consent Solicitation, including the Co-Issuer's obligation to accept the Notes tendered and pay the purchase price therefor, are set forth in the Offer to Purchase and Consent Solicitation Statement. The Co-Issuers may amend, extend or, subject to certain conditions, terminate the Tender Offer and Consent Solicitation, in their sole discretion.

This press release does not constitute a notice of redemption under the optional redemption provisions of the indenture governing the Notes, nor does it constitute an offer to sell, or a solicitation of an offer to buy, any security. No offer, solicitation, or sale will be made in any jurisdiction in which such an offer, solicitation, or sale would be unlawful.

If you liked this article you might like

Experimental Tau Protein Drug Tangled Up in Late-Stage Alzheimer's Study Failure

With Martin Shkreli Long Gone, Retrophin is an 'Interesting Opportunity'

Despite Shkreli Drama, Retrophin Looks Interesting Now

Celtic Tiger Tries to Roar Again

Cramer's 6 Stocks in 60 Seconds: PRGO CREE HOG GME ORCL MHK (Update 1)